Humana Inc. (NYSE:HUM) Shares Purchased by APG Asset Management N.V.

APG Asset Management N.V. lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 230.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 86,229 shares of the insurance provider's stock after purchasing an additional 60,098 shares during the period. APG Asset Management N.V. owned about 0.07% of Humana worth $21,127,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. Norges Bank acquired a new stake in Humana in the 4th quarter valued at $416,202,000. Pzena Investment Management LLC increased its holdings in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares in the last quarter. Boston Partners raised its position in Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the period. Finally, Invesco Ltd. lifted its holdings in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after purchasing an additional 550,692 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Remove Ads

Humana Trading Up 0.1 %

NYSE:HUM traded up $0.16 on Tuesday, reaching $284.98. The company's stock had a trading volume of 360,440 shares, compared to its average volume of 1,745,740. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The stock has a 50 day moving average price of $265.43 and a 200 day moving average price of $270.11. The firm has a market cap of $34.40 billion, a price-to-earnings ratio of 28.64, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.24%. Humana's payout ratio is currently 35.58%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Guggenheim began coverage on shares of Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target for the company. StockNews.com raised Humana from a "hold" rating to a "buy" rating in a report on Monday, April 7th. Robert W. Baird raised their target price on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday. JPMorgan Chase & Co. reduced their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Finally, Truist Financial lifted their target price on shares of Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research note on Friday. Seventeen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Humana currently has a consensus rating of "Hold" and a consensus target price of $284.90.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.